Rezpira Special Precautions

Rezpira should not be used to treat acute asthma symptoms for which a fast- and short-acting bronchodilator is required. Patients should be advised to have their inhaler to be used for relief in an acute asthma attack available at all times. Treatment with Rezpira should not be stopped abruptly. Both non-selective and selective beta-blockers should be avoided in patients with asthma, unless there are compelling reasons for their use. As with all inhaled medication containing corticosteroids, it should be administered with caution in patients with active or quiescent pulmonary tuberculosis. Rezpira should be administered with caution in patients with severe thyrotoxicosis.
Special patient groups: There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of Rezpira in patients with hepatic impairment.
Use in Children: Orally inhaled corticosteroids may cause a reduction in growth velocity when administered to pediatric patients. The long term effects of this reduction including the impact of final adult height are unknown.